Picture of Grand Pharmaceutical logo

512 Grand Pharmaceutical Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Grand Pharmaceutical, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line1,3562,0742,7862,517
Depreciation
Amortisation
Non-Cash Items-41.9-417-544173
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-487-488-576-1,242
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,3041,4562,0061,843
Capital Expenditures-599-279-536-1,085
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items156-1,235-1,233-1,275
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-444-1,513-1,769-2,360
Financing Cash Flow Items-232-132-159-145
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-710774-333327
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash147777-83.8-309